Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Scheer

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2021
Intrinsic physicochemical profile of marketed antibody-based biotherapeuticsLucky Ahmed, Priyanka Gupta, Kyle P Martin, et al.
Journal of Molecular Biology|March 1, 2014
Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interactionJ Michael Elliott, Mark Ultsch, Joshua Lee, et al.
Mabs|September 30, 2016
An efficient route to bispecific antibody production using single-reactor mammalian co-cultureWhitney Shatz, Domingos Ng, George Dutina, et al.
Mabs|September 3, 2013
Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicityWhitney Shatz, Shan Chung, Bing Li, et al.
Plos One|January 4, 2013
Reorienting the Fab domains of trastuzumab results in potent HER2 activatorsJustin M Scheer, Wendy Sandoval, J Michael Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2020
A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces Antitumor Responses in Small Cell Lung CancerSusanne Hipp, Vladimir Voynov, Barbara Drobits-Handl, et al.
ACS Chemical Biology|March 16, 2024
Geometric Antibody Engineering Reveals the Spatial Factor on the Efficacy of Bispecific T Cell EngagersYu Zhang, Zhe Yang, Dilizhatai Saimi, et al.
Blood|June 3, 2020
Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemiaChristine Tran Quang, Benedetta Zaniboni, Romain Humeau, et al.
Nature Biotechnology|July 9, 2013
Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodiesChristoph Spiess, Mark Merchant, Arthur Huang, et al.
Mabs|January 27, 2017
bisFabs: Tools for rapidly screening hybridoma IgGs for their activities as bispecific antibodiesSanket Patke, Ji Li, Peiyin Wang, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2021
Intrinsic physicochemical profile of marketed antibody-based biotherapeuticsLucky Ahmed, Priyanka Gupta, Kyle P Martin, et al.
Journal of Molecular Biology|March 1, 2014
Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interactionJ Michael Elliott, Mark Ultsch, Joshua Lee, et al.
Mabs|September 30, 2016
An efficient route to bispecific antibody production using single-reactor mammalian co-cultureWhitney Shatz, Domingos Ng, George Dutina, et al.
Mabs|September 3, 2013
Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicityWhitney Shatz, Shan Chung, Bing Li, et al.
Plos One|January 4, 2013
Reorienting the Fab domains of trastuzumab results in potent HER2 activatorsJustin M Scheer, Wendy Sandoval, J Michael Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2020
A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces Antitumor Responses in Small Cell Lung CancerSusanne Hipp, Vladimir Voynov, Barbara Drobits-Handl, et al.
ACS Chemical Biology|March 16, 2024
Geometric Antibody Engineering Reveals the Spatial Factor on the Efficacy of Bispecific T Cell EngagersYu Zhang, Zhe Yang, Dilizhatai Saimi, et al.
Blood|June 3, 2020
Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemiaChristine Tran Quang, Benedetta Zaniboni, Romain Humeau, et al.
Nature Biotechnology|July 9, 2013
Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodiesChristoph Spiess, Mark Merchant, Arthur Huang, et al.
Mabs|January 27, 2017
bisFabs: Tools for rapidly screening hybridoma IgGs for their activities as bispecific antibodiesSanket Patke, Ji Li, Peiyin Wang, et al.
Pageof 4